Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

Rodger, Marc; R. Kahn, Susan; S. Wells, Philip; R. Anderson, David; Chagnon, Isabelle; Le Gal, Grégoire; Solymoss, Susan; Crowther, Mark; Perrier, Arnaud; White, R.; Vickars, L.; Ramsay, Tim; T. Betancourt, Marisol; Kovacs, M.J.

doi:10.1503/cmaj.080493

Public

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

Published in Canadian Medical Association Journal • Jul 17, 2008

Authors:

Marc Rodger

Susan R. Kahn

Philip S. Wells

Abstract

BACKGROUND: Whether to continue oral anticoagulant therapy beyond 6 months after an "unprovoked" venous thromboembolism is controversial. We sought to determine clinical predictors to identify patients who are at low risk of recurrent venous thromboembolism who could safely discontinue oral anticoag...

Subject

Medicine

Warfarin

Venous thromboembolism

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!